Ascelia Pharma (Sweden) Price Patterns
| ACE Stock | SEK 3.27 0.22 7.21% |
Momentum 42
Sell Extended
Oversold | Overbought |
Using Ascelia Pharma hype-based prediction, you can estimate the value of Ascelia Pharma AB from the perspective of Ascelia Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ascelia Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ascelia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ascelia Pharma after-hype prediction price | SEK 3.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ascelia |
Ascelia Pharma After-Hype Price Density Analysis
As far as predicting the price of Ascelia Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ascelia Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ascelia Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ascelia Pharma Estimiated After-Hype Price Volatility
In the context of predicting Ascelia Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ascelia Pharma's historical news coverage. Ascelia Pharma's after-hype downside and upside margins for the prediction period are 0.16 and 6.64, respectively. We have considered Ascelia Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ascelia Pharma is unstable at this time. Analysis and calculation of next after-hype price of Ascelia Pharma AB is based on 3 months time horizon.
Ascelia Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Ascelia Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ascelia Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ascelia Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 3.37 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.27 | 3.27 | 0.00 |
|
Ascelia Pharma Hype Timeline
Ascelia Pharma AB is presently traded for 3.27on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ascelia is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.32%. %. The volatility of related hype on Ascelia Pharma is about 0.0%, with the expected price after the next announcement by competition of 3.27. About 23.0% of the company shares are held by company insiders. The book value of Ascelia Pharma was presently reported as 5.19. The company recorded a loss per share of 3.67. Ascelia Pharma AB had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Ascelia Pharma Basic Forecasting Models to cross-verify your projections.Ascelia Pharma Related Hype Analysis
Having access to credible news sources related to Ascelia Pharma's direct competition is more important than ever and may enhance your ability to predict Ascelia Pharma's future price movements. Getting to know how Ascelia Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ascelia Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IMMU | Mendus AB | 0.00 | 0 per month | 0.00 | (0.11) | 6.32 | (7.51) | 21.62 | |
| IVACC | Intervacc AB | 0.00 | 0 per month | 0.00 | (0.06) | 4.44 | (3.33) | 22.88 | |
| MAGLE | Magle Chemoswed Holding | 0.00 | 0 per month | 0.00 | (0.24) | 6.21 | (8.22) | 20.42 | |
| XINT | Xintela AB | 0.00 | 0 per month | 0.00 | (0.09) | 6.67 | (7.14) | 31.58 | |
| MOB | Moberg Pharma AB | 0.00 | 0 per month | 0.00 | (0.11) | 3.54 | (4.26) | 9.16 | |
| KDEV | Karolinska Development AB | 0.00 | 0 per month | 0.00 | (0.15) | 11.54 | (13.16) | 47.86 | |
| ELIC | Elicera Therapeutics AB | 0.00 | 0 per month | 0.00 | (0.08) | 5.36 | (4.29) | 27.92 | |
| ISOFOL | Isofol Medical AB | 0.00 | 0 per month | 0.00 | (0.15) | 2.86 | (3.12) | 9.88 | |
| LIPUM | Lipum AB | 0.00 | 0 per month | 2.38 | 0.03 | 2.76 | (1.92) | 24.12 | |
| IRLAB-A | IRLAB Therapeutics AB | 0.00 | 0 per month | 0.00 | (0.16) | 4.79 | (5.56) | 14.42 |
Ascelia Pharma Additional Predictive Modules
Most predictive techniques to examine Ascelia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascelia using various technical indicators. When you analyze Ascelia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascelia Pharma Predictive Indicators
The successful prediction of Ascelia Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascelia Pharma AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascelia Pharma based on analysis of Ascelia Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ascelia Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ascelia Pharma's related companies.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.